Category: Latest News

  • IperionX Shares Drop After Spruce Point Issues Critical Short Report

    IperionX Shares Drop After Spruce Point Issues Critical Short Report

    IperionX Limited ADR (NASDAQ:IPX) shares fell 5.6% in premarket trading Wednesday after Spruce Point Capital Management published a short report on the titanium producer, warning of a potential long-term downside of 70% to 95% under certain conditions. The New York-based investment firm raised doubts about IperionX’s commercial prospects and valuation in a report titled “A…

  • DBV Technologies Shares Jump After Completing Final Phase of VITESSE Peanut Allergy Trial

    DBV Technologies Shares Jump After Completing Final Phase of VITESSE Peanut Allergy Trial

    DBV Technologies (NASDAQ:DBVT) shares surged 7.2% in premarket trading on Wednesday after the French biopharmaceutical company announced the completion of the final patient visit in its Phase 3 VITESSE trial evaluating the VIASKIN Peanut patch. The study assesses the efficacy and safety of the VIASKIN Peanut patch in children aged 4 to 7 years with…

  • BIO-Key Shares Surge After Strategic Partnership With VaporVM

    BIO-Key Shares Surge After Strategic Partnership With VaporVM

    BIO-Key International, Inc. (NASDAQ:BKYI) shares jumped 9.7% in premarket trading on Wednesday after the company announced a strategic partnership with Dubai-based cloud and cybersecurity firm VaporVM. The collaboration is designed to expand BIO-Key’s presence across the Middle East and Africa, combining its advanced identity authentication technologies with VaporVM’s strong regional network and market expertise. As…

  • Alkermes Shares Plunge After Mixed Market Reaction to Narcolepsy Drug Trial Results

    Alkermes Shares Plunge After Mixed Market Reaction to Narcolepsy Drug Trial Results

    Alkermes (NASDAQ:ALKS) shares fell 15% after the company released topline results from its Vibrance-2 Phase 2 trial of alixorexton in patients with narcolepsy type 2. Despite demonstrating strong efficacy, the data failed to fully convince investors. The Dublin-based biopharma firm reported that alixorexton met both primary endpoints, showing statistically significant improvements in wakefulness and excessive…

  • Vista Energy Unveils Plan to Boost Oil Output by 50% by 2030

    Vista Energy Unveils Plan to Boost Oil Output by 50% by 2030

    Vista Energy (NYSE:VIST) announced an ambitious new growth strategy targeting a 50% increase in shale oil production by 2030, rising from 130,000 barrels of oil equivalent per day (boe/d) in the second half of 2025 to over 200,000 boe/d by the end of the decade. During its capital markets day, the company outlined plans to…

  • Amentum Shares Rise After Securing $995 Million U.S. Air Force Contract

    Amentum Shares Rise After Securing $995 Million U.S. Air Force Contract

    Amentum (NYSE:AMTM) shares climbed 2% in U.S. premarket trading after the company announced it had won a major contract worth up to $995 million from the U.S. Air Force Air Combat Command to provide Remotely Piloted Aircraft Maintenance Support. The Indefinite Delivery/Indefinite Quantity (IDIQ) contract will run for a five-year ordering period, supporting the modernization…

  • BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership

    BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership

    BioNexus Gene Lab Corp. (NASDAQ:BGLC) shares jumped 10% after the company announced strategic agreements with Fidelion Diagnostics to jointly commercialize VitaGuard, a next-generation liquid biopsy platform for minimal residual disease (MRD) testing across Southeast Asia. Under the definitive agreements, BioNexus will acquire newly issued Fidelion shares representing at least 15% of Fidelion’s fully diluted equity,…

  • Arcos Dorados Shares Gain 4% as Q3 Results Meet Estimates and Sales Expand

    Arcos Dorados Shares Gain 4% as Q3 Results Meet Estimates and Sales Expand

    Arcos Dorados Holdings Inc. (NYSE:ARCO) — the world’s largest independent McDonald’s franchisee — reported third-quarter 2025 results that met earnings expectations while delivering solid sales growth, sending its shares up 4.0% in pre-market trading on Wednesday. The company posted adjusted earnings of $0.71 per share, a sharp increase from $0.17 per share in the same…

  • Gilat Satellite Networks Shares Jump 7% as Earnings and Revenue Beat Expectations

    Gilat Satellite Networks Shares Jump 7% as Earnings and Revenue Beat Expectations

    Gilat Satellite Networks Ltd. (NASDAQ:GILT) shares climbed 7.1% in pre-market trading on Wednesday after the satellite communications company posted strong third-quarter results that surpassed analyst forecasts, boosted by broad-based revenue growth across its core markets. The company reported adjusted earnings of $0.19 per share, easily topping consensus estimates of $0.11. Revenue surged 58% year-over-year to…

  • TransDigm Shares Slip as Fiscal 2026 Guidance Falls Short of Expectations

    TransDigm Shares Slip as Fiscal 2026 Guidance Falls Short of Expectations

    TransDigm Group (NYSE:TDG) shares fell 2.6% in pre-market trading on Wednesday, after the aerospace components manufacturer issued fiscal 2026 guidance that disappointed some investors, despite posting strong fourth-quarter results ahead of analyst forecasts. The company reported adjusted earnings of $10.82 per share for the fourth quarter, topping consensus estimates of $10.07. Revenue rose 11.5% year-over-year…